BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/28/2019 9:29:28 AM | Browse: 930 | Download: 1870
 |
Received |
|
2019-09-29 15:53 |
|
Peer-Review Started |
|
2019-09-29 15:55 |
|
First Decision by Editorial Office Director |
|
2019-11-10 05:37 |
|
Return for Revision |
|
2019-11-10 05:37 |
|
Revised |
|
2019-11-27 05:29 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2019-12-12 10:45 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2019-12-13 01:24 |
|
Articles in Press |
|
2019-12-13 01:24 |
|
Edit the Manuscript by Language Editor |
|
2019-12-24 02:14 |
|
Typeset the Manuscript |
|
2019-12-27 08:21 |
|
Publish the Manuscript Online |
|
2019-12-28 09:29 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Case Control Study |
| Article Title |
Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yong-Lian Zeng, Zhen-Ya Guo, Hui-Zhao Su, Fu-Di Zhong, Ke-Qing Jiang and Guan-Dou Yuan |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Guan-Dou Yuan, MSc, Director, Director, Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, No. 6, Shuangyong Road, Nanning 530021, Guangxi Zhuang Autonomous Region, China. yuan25958282@163.com |
| Key Words |
LncRNA Cancer susceptibility candidate 9; Hepatocellular carcinoma; Prognosis; Kyoto Encyclopedia of Genes and Genomes; Gene ontology; CeRNA |
| Core Tip |
Previous studies have found that lncRNA Cancer susceptibility candidate 9 (CASC9) can promote the survival of hepatocellular carcinoma (HCC) cells through AKTions, but it is not clear whether lncRNA CASC9 can be used as a clinical diagnosis and prognosis indicator for patients with HCC. This study has confirmed that lncRNA CASC9 can be used as a potential prognostic and diagnostic indicator for patients with HCC and it may be a potential therapeutic target for HCC. |
| Publish Date |
2019-12-28 09:29 |
| Citation |
Zeng YL, Guo ZY, Su HZ, Zhong FD, Jiang KQ, Yuan GD, Diagnostic and prognostic value of lncRNA Cancer susceptibility candidate 9 in hepatocellular carcinoma. World J Gastroenterol 2019; 25(48): 6902-6915 |
| URL |
https://www.wjgnet.com/1007-9327/full/v25/i48/6902.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v25.i48.6902 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
